Medical Science News

RSS

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

As the exact zoonotic origin of SARS-CoV-2 remains unresolved, scientists at the Francis Crick Institute in London, UK, explored the structure and binding properties of a Pangolin coronavirus spike glycoprotein to see if it could shed light on the evolution of SARS-CoV-2.

16 Feb 2021

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Using different UV exposure times and dosages, researchers showed that surfaces like glass, plastic, stainless steel, and N95 respirator material could be quickly and easily disinfected.

16 Feb 2021

Daily caffeine consumption can change the gray matter of the brain

Coffee, cola or an energy drink: caffeine is the world's most widely consumed psychoactive substance. Researchers from the University of Basel have now shown in a study that regular caffeine intake can change the gray matter of the brain. However, the effect appears to be temporary.

16 Feb 2021

Scientists discover two unique subtypes of a prominent mutation in patients with AML

Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute Myeloid Leukemia (AML) – called NPM1 – that could help predict survival and improve treatment response for patients whose leukemic cells bear the mutation.

16 Feb 2021

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

A team of scientists from Germany and the USA recently explored the effectiveness of traditional plant medicines in treating SARS-CoV-2 infection.

16 Feb 2021

What are the changes in the physical phenotype of blood cells in COVID-19?

While primarily a respiratory illness, there are distinctive alterations in the type and number of blood cells in COVID-19. A new study by a team of researchers in Germany describes the nature of these changes.

16 Feb 2021

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Researchers in France report impaired neutralization of two new SARS-CoV-2 variants by antibodies induced by vaccination or natural infection.

16 Feb 2021

Researchers create new cancer optotheranostics based on photosynthetic bacteria

Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.

16 Feb 2021

Study: The brain has a small window of opportunity to repair itself after stroke

An international study has shown, for the first time, that the capacity of the human brain to recover and rewire itself peaks around two weeks after a stroke and diminishes over time.

16 Feb 2021

Genetic testing technology wrongly detects the presence of very rare genetic variants

A technology that is widely used by commercial genetic testing companies is "extremely unreliable" in detecting very rare variants, meaning results suggesting individuals carry rare disease-causing genetic variants are usually wrong, according to new research published in the BMJ.

15 Feb 2021

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.

15 Feb 2021

UTEP professor's discovery could lead to a way to inhibit overeating

Science is a step closer to a new response to obesity, thanks in part to a study conducted by a team that included Sergio Iñiguez, Ph.D., associate professor of psychology at The University of Texas at El Paso.

15 Feb 2021

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.

15 Feb 2021

Controlling cardiovascular disease risk factors early in life may protect against later dementia

Employing cardiovascular disease prevention strategies in mid-life may delay or stop the brain alterations that can lead to dementia later in life, according to a study in the Journal of the American College of Cardiology.

15 Feb 2021

First wearable device for simultaneous monitoring of cardiovascular signals and biochemical levels

Engineers at the University of California San Diego have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol or caffeine.

15 Feb 2021

Study finds link between brain metabolism, cardiovascular risk, and atherosclerosis

The links between cardiovascular disease and cognitive impairment begin years before the appearance of the first clinical symptoms of either condition.

15 Feb 2021

New type of surgery can help amputees better control their residual muscles

MIT researchers have invented a new type of amputation surgery that can help amputees to better control their residual muscles and sense where their "phantom limb" is in space.

15 Feb 2021

Researchers report a new SARS-CoV-2 variant of concern in Uganda

An interdisciplinary research team from Uganda and the UK report the emergence and spread of a new SARS-CoV-2 variant of the A lineage with multiple protein changes throughout the viral genome.

15 Feb 2021

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

Researchers found that neutralizing antibodies against SARS-CoV-2 can increase over time. They observed that samples taken from convalescent plasma in September 2020 would likely have high enough values by July 2021 to protect immunodeficient patients who receive intravenous immunoglobulins as part of their treatment.

15 Feb 2021

Scientists discover new immunotherapy target for malignant brain tumors

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body's immune system.

15 Feb 2021

Medical Science News

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Daily caffeine consumption can change the gray matter of the brain

Scientists discover two unique subtypes of a prominent mutation in patients with AML

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

What are the changes in the physical phenotype of blood cells in COVID-19?

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Researchers create new cancer optotheranostics based on photosynthetic bacteria

Study: The brain has a small window of opportunity to repair itself after stroke

Genetic testing technology wrongly detects the presence of very rare genetic variants

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

UTEP professor's discovery could lead to a way to inhibit overeating

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

Controlling cardiovascular disease risk factors early in life may protect against later dementia

First wearable device for simultaneous monitoring of cardiovascular signals and biochemical levels

Study finds link between brain metabolism, cardiovascular risk, and atherosclerosis

New type of surgery can help amputees better control their residual muscles

Researchers report a new SARS-CoV-2 variant of concern in Uganda

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

Scientists discover new immunotherapy target for malignant brain tumors

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News